[1] World Health Organization. Global Status report on alcohol and health. 2018.
[2] Singal AK, Bataller R, Ahn J, et al. ACG Clinical Guideline: Alcoholic Liver Disease. Am J Gastroenterol, 2018, 113: 175-194.
[3] Lucey MR, Im GY, Mellinger JL, et al. Introducing the 2019 American Association for the Study of Liver Diseases Guidance on Alcohol-Associated Liver Disease. Liver Transpl, 2020, 26: 14-16.
[4] Askgaard G, Leon DA, Kjaer MS, et al. Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort study. Hepatology, 2017, 65: 929-937.
[5] Rae JP, Donna ME, Jia Y, el al. A randomized controlled trial of an integrated alcohol reduction intervention in patients with hepatitis C infection. Hepatology, 2020, 71: 1894-1909.
[6] Rogal SYA, Zang H, Gellad W, et al. The impact of alcohol use disorder treatments on clinical outcomes among Veterans with cirrhosis. Hepatology, 2020, 71: 2080-2092.
[7] Grant BF, Saha TD, Ruan WJ, et al. Epidemiology of DSM-5 drug use disorder: results from the national epidemiologic survey on alcohol and related conditions-III. JAMA Psychiat,2016,73: 39-47.
[8] Mellinger JL, Fernandez A, Shedden K, et al. Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis. Alcohol Clin Exp Res, 2019, 43: 334-341.
[9] Mellinger JL, Scott Winder G, DeJonckheere M, et al. Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis. J Subst Abuse Treat 2018, 91: 20-27.
[10] Weinrieb RM, Van Horn DH, Lynch KG, et al. A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation. Liver Transpl, 2011, 17: 539-547. |
